Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
12,214
archived clinical trials in
Women's Studies

Cisplatin and Radiation Therapy With or Without Triapine in Treating Patients With Previously Untreated Stage IB-IVA Cervical Cancer or Stage II-IVA Vaginal Cancer
Randomized Phase II Study of Intravenous 3-Aminopyridine-2-Carboxaldehyde Thiosemicarbazone (3-AP, Triapine® NSC #663249) Cisplatin-Radiochemotherapy Versus Intravenous Cisplatin-Radiochemotherapy in Women Diagnosed With Stage IB-IVA Cervical Cancer and Stage II-IVA Vaginal Cancer
Status: Enrolling
Updated:  3/25/2016
Moffitt Cancer Center
mi
from
Tampa, FL
Cisplatin and Radiation Therapy With or Without Triapine in Treating Patients With Previously Untreated Stage IB-IVA Cervical Cancer or Stage II-IVA Vaginal Cancer
Randomized Phase II Study of Intravenous 3-Aminopyridine-2-Carboxaldehyde Thiosemicarbazone (3-AP, Triapine® NSC #663249) Cisplatin-Radiochemotherapy Versus Intravenous Cisplatin-Radiochemotherapy in Women Diagnosed With Stage IB-IVA Cervical Cancer and Stage II-IVA Vaginal Cancer
Status: Enrolling
Updated: 3/25/2016
Moffitt Cancer Center
mi
from
Tampa, FL
Click here to add this to my saved trials
Cisplatin and Radiation Therapy With or Without Triapine in Treating Patients With Previously Untreated Stage IB-IVA Cervical Cancer or Stage II-IVA Vaginal Cancer
Randomized Phase II Study of Intravenous 3-Aminopyridine-2-Carboxaldehyde Thiosemicarbazone (3-AP, Triapine® NSC #663249) Cisplatin-Radiochemotherapy Versus Intravenous Cisplatin-Radiochemotherapy in Women Diagnosed With Stage IB-IVA Cervical Cancer and Stage II-IVA Vaginal Cancer
Status: Enrolling
Updated:  3/25/2016
Summa Akron City Hospital/Cooper Cancer Center
mi
from
Akron, OH
Cisplatin and Radiation Therapy With or Without Triapine in Treating Patients With Previously Untreated Stage IB-IVA Cervical Cancer or Stage II-IVA Vaginal Cancer
Randomized Phase II Study of Intravenous 3-Aminopyridine-2-Carboxaldehyde Thiosemicarbazone (3-AP, Triapine® NSC #663249) Cisplatin-Radiochemotherapy Versus Intravenous Cisplatin-Radiochemotherapy in Women Diagnosed With Stage IB-IVA Cervical Cancer and Stage II-IVA Vaginal Cancer
Status: Enrolling
Updated: 3/25/2016
Summa Akron City Hospital/Cooper Cancer Center
mi
from
Akron, OH
Click here to add this to my saved trials
Family Nurture Intervention in the CHoNJ NICU
Randomized Control Trial of Family Nurture Intervention in the Children's Hospital of New Jersey Neonatal Intensive Care Unit
Status: Enrolling
Updated:  3/25/2016
Children's Hospital of New Jersey
mi
from
Newark, NJ
Family Nurture Intervention in the CHoNJ NICU
Randomized Control Trial of Family Nurture Intervention in the Children's Hospital of New Jersey Neonatal Intensive Care Unit
Status: Enrolling
Updated: 3/25/2016
Children's Hospital of New Jersey
mi
from
Newark, NJ
Click here to add this to my saved trials
Family Nurture Intervention in the CHoNJ NICU
Randomized Control Trial of Family Nurture Intervention in the Children's Hospital of New Jersey Neonatal Intensive Care Unit
Status: Enrolling
Updated:  3/25/2016
Columbia University Data Coordinating Center
mi
from
New York, NY
Family Nurture Intervention in the CHoNJ NICU
Randomized Control Trial of Family Nurture Intervention in the Children's Hospital of New Jersey Neonatal Intensive Care Unit
Status: Enrolling
Updated: 3/25/2016
Columbia University Data Coordinating Center
mi
from
New York, NY
Click here to add this to my saved trials
Early Detection of Ovarian Cancer: GC/FT-ICR Mass Spectrometry and Canine Olfaction
Early Detection of Epithelial Ovarian Cancer Using Exhaled Breath Markers: GC/FT-ICR Mass Spectrometry and Canine Olfaction.
Status: Enrolling
Updated:  3/28/2016
Pine Street Foundation
mi
from
San Anselmo, CA
Early Detection of Ovarian Cancer: GC/FT-ICR Mass Spectrometry and Canine Olfaction
Early Detection of Epithelial Ovarian Cancer Using Exhaled Breath Markers: GC/FT-ICR Mass Spectrometry and Canine Olfaction.
Status: Enrolling
Updated: 3/28/2016
Pine Street Foundation
mi
from
San Anselmo, CA
Click here to add this to my saved trials
Early Detection of Ovarian Cancer: GC/FT-ICR Mass Spectrometry and Canine Olfaction
Early Detection of Epithelial Ovarian Cancer Using Exhaled Breath Markers: GC/FT-ICR Mass Spectrometry and Canine Olfaction.
Status: Enrolling
Updated:  3/28/2016
UCSF Helen Diller Family Comprehensive Cancer Center
mi
from
San Francisco, CA
Early Detection of Ovarian Cancer: GC/FT-ICR Mass Spectrometry and Canine Olfaction
Early Detection of Epithelial Ovarian Cancer Using Exhaled Breath Markers: GC/FT-ICR Mass Spectrometry and Canine Olfaction.
Status: Enrolling
Updated: 3/28/2016
UCSF Helen Diller Family Comprehensive Cancer Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Early Detection of Ovarian Cancer: GC/FT-ICR Mass Spectrometry and Canine Olfaction
Early Detection of Epithelial Ovarian Cancer Using Exhaled Breath Markers: GC/FT-ICR Mass Spectrometry and Canine Olfaction.
Status: Enrolling
Updated:  3/28/2016
California Pacific Medical Center - California Campus
mi
from
San Francisco, CA
Early Detection of Ovarian Cancer: GC/FT-ICR Mass Spectrometry and Canine Olfaction
Early Detection of Epithelial Ovarian Cancer Using Exhaled Breath Markers: GC/FT-ICR Mass Spectrometry and Canine Olfaction.
Status: Enrolling
Updated: 3/28/2016
California Pacific Medical Center - California Campus
mi
from
San Francisco, CA
Click here to add this to my saved trials
Early Detection of Ovarian Cancer: GC/FT-ICR Mass Spectrometry and Canine Olfaction
Early Detection of Epithelial Ovarian Cancer Using Exhaled Breath Markers: GC/FT-ICR Mass Spectrometry and Canine Olfaction.
Status: Enrolling
Updated:  3/28/2016
University of Maine
mi
from
Orono, ME
Early Detection of Ovarian Cancer: GC/FT-ICR Mass Spectrometry and Canine Olfaction
Early Detection of Epithelial Ovarian Cancer Using Exhaled Breath Markers: GC/FT-ICR Mass Spectrometry and Canine Olfaction.
Status: Enrolling
Updated: 3/28/2016
University of Maine
mi
from
Orono, ME
Click here to add this to my saved trials
Nurse Family Partnership (NFP) Contraceptive Study
Effectiveness of Home Based Distribution of Hormonal Contraceptives for Women at Risk for Unintended Pregnancy
Status: Enrolling
Updated:  3/28/2016
Thurston County Public Health
mi
from
Olympia, WA
Nurse Family Partnership (NFP) Contraceptive Study
Effectiveness of Home Based Distribution of Hormonal Contraceptives for Women at Risk for Unintended Pregnancy
Status: Enrolling
Updated: 3/28/2016
Thurston County Public Health
mi
from
Olympia, WA
Click here to add this to my saved trials
Nurse Family Partnership (NFP) Contraceptive Study
Effectiveness of Home Based Distribution of Hormonal Contraceptives for Women at Risk for Unintended Pregnancy
Status: Enrolling
Updated:  3/28/2016
Seattle - King County Public Health
mi
from
Seattle, WA
Nurse Family Partnership (NFP) Contraceptive Study
Effectiveness of Home Based Distribution of Hormonal Contraceptives for Women at Risk for Unintended Pregnancy
Status: Enrolling
Updated: 3/28/2016
Seattle - King County Public Health
mi
from
Seattle, WA
Click here to add this to my saved trials
Nurse Family Partnership (NFP) Contraceptive Study
Effectiveness of Home Based Distribution of Hormonal Contraceptives for Women at Risk for Unintended Pregnancy
Status: Enrolling
Updated:  3/28/2016
Clark County Public Health
mi
from
Vancouver, WA
Nurse Family Partnership (NFP) Contraceptive Study
Effectiveness of Home Based Distribution of Hormonal Contraceptives for Women at Risk for Unintended Pregnancy
Status: Enrolling
Updated: 3/28/2016
Clark County Public Health
mi
from
Vancouver, WA
Click here to add this to my saved trials
Prematurity and Respiratory Outcomes Program (PROP)
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated:  3/28/2016
Alta Bates Summit Medical Center
mi
from
Oakland, CA
Prematurity and Respiratory Outcomes Program (PROP)
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated: 3/28/2016
Alta Bates Summit Medical Center
mi
from
Oakland, CA
Click here to add this to my saved trials
Prematurity and Respiratory Outcomes Program (PROP)
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated:  3/28/2016
Indiana University Health/Riley Hospital for Children
mi
from
Indianapolis, IN
Prematurity and Respiratory Outcomes Program (PROP)
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated: 3/28/2016
Indiana University Health/Riley Hospital for Children
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Prematurity and Respiratory Outcomes Program (PROP)
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated:  3/28/2016
Washington Universitiy
mi
from
St Louis, MO
Prematurity and Respiratory Outcomes Program (PROP)
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated: 3/28/2016
Washington Universitiy
mi
from
St Louis, MO
Click here to add this to my saved trials
Prematurity and Respiratory Outcomes Program (PROP)
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated:  3/28/2016
University at Buffalo
mi
from
Buffalo, NY
Prematurity and Respiratory Outcomes Program (PROP)
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated: 3/28/2016
University at Buffalo
mi
from
Buffalo, NY
Click here to add this to my saved trials
Prematurity and Respiratory Outcomes Program (PROP)
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated:  3/28/2016
University of Rochester
mi
from
Rochester, NY
Prematurity and Respiratory Outcomes Program (PROP)
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated: 3/28/2016
University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
Prematurity and Respiratory Outcomes Program (PROP)
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated:  3/28/2016
Duke Univ Med Ctr
mi
from
Durham, NC
Prematurity and Respiratory Outcomes Program (PROP)
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated: 3/28/2016
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Prematurity and Respiratory Outcomes Program (PROP)
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated:  3/28/2016
Cincinnati University Hospital
mi
from
Cincinnati, OH
Prematurity and Respiratory Outcomes Program (PROP)
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated: 3/28/2016
Cincinnati University Hospital
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Prematurity and Respiratory Outcomes Program (PROP)
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated:  3/28/2016
Good Samaritan Hospital
mi
from
Cincinnati, OH
Prematurity and Respiratory Outcomes Program (PROP)
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated: 3/28/2016
Good Samaritan Hospital
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Prematurity and Respiratory Outcomes Program (PROP)
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated:  3/28/2016
Jackson Madison County General Hospital
mi
from
Jackson, TN
Prematurity and Respiratory Outcomes Program (PROP)
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated: 3/28/2016
Jackson Madison County General Hospital
mi
from
Jackson, TN
Click here to add this to my saved trials
Prematurity and Respiratory Outcomes Program (PROP)
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated:  3/28/2016
Monroe Carell Jr. Children's Hospital at Vanderbilt
mi
from
Nashville, TN
Prematurity and Respiratory Outcomes Program (PROP)
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated: 3/28/2016
Monroe Carell Jr. Children's Hospital at Vanderbilt
mi
from
Nashville, TN
Click here to add this to my saved trials
Prematurity and Respiratory Outcomes Program (PROP)
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated:  3/28/2016
University of California at San Francisco
mi
from
San Francisco, CA
Prematurity and Respiratory Outcomes Program (PROP)
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated: 3/28/2016
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Prematurity and Respiratory Outcomes Program (PROP)
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated:  3/28/2016
Cincinnati Children's Hospital
mi
from
Cincinnati, OH
Prematurity and Respiratory Outcomes Program (PROP)
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated: 3/28/2016
Cincinnati Children's Hospital
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Prematurity and Respiratory Outcomes Program (PROP)
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated:  3/28/2016
The University of Texas, Houston
mi
from
Houston, TX
Prematurity and Respiratory Outcomes Program (PROP)
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated: 3/28/2016
The University of Texas, Houston
mi
from
Houston, TX
Click here to add this to my saved trials
A Mixed-Methods Approach to Understanding Factors Associated With Cervical Cancer Screening Utilization Among Low-Income, HIV-Positive Women
A Mixed-Methods Approach to Understanding Factors Associated With Cervical Cancer Screening Utilization Among Low-Income, HIV-Positive Women
Status: Enrolling
Updated:  3/28/2016
Thomas Street Health Center, Harris County Hospital District
mi
from
Houston, TX
A Mixed-Methods Approach to Understanding Factors Associated With Cervical Cancer Screening Utilization Among Low-Income, HIV-Positive Women
A Mixed-Methods Approach to Understanding Factors Associated With Cervical Cancer Screening Utilization Among Low-Income, HIV-Positive Women
Status: Enrolling
Updated: 3/28/2016
Thomas Street Health Center, Harris County Hospital District
mi
from
Houston, TX
Click here to add this to my saved trials
Tamoxifen for the Treatment of Unfavorable Bleeding in Contraceptive Implant Users
Tamoxifen for the Treatment of Unfavorable Bleeding Patterns in Etonogestrel Contraceptive Implant Users
Status: Enrolling
Updated:  3/28/2016
Oregon Health & Science University (OHSU)
mi
from
Portland, OR
Tamoxifen for the Treatment of Unfavorable Bleeding in Contraceptive Implant Users
Tamoxifen for the Treatment of Unfavorable Bleeding Patterns in Etonogestrel Contraceptive Implant Users
Status: Enrolling
Updated: 3/28/2016
Oregon Health & Science University (OHSU)
mi
from
Portland, OR
Click here to add this to my saved trials
Lifestyle and Fertility Study on Antioxidant Status, Diet and Early Pregnancy
Antioxidant Status, Diet and Early Pregnancy
Status: Enrolling
Updated:  3/30/2016
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Lifestyle and Fertility Study on Antioxidant Status, Diet and Early Pregnancy
Antioxidant Status, Diet and Early Pregnancy
Status: Enrolling
Updated: 3/30/2016
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
Lifestyle and Fertility Study on Antioxidant Status, Diet and Early Pregnancy
Antioxidant Status, Diet and Early Pregnancy
Status: Enrolling
Updated:  3/30/2016
Penn State University
mi
from
University Park, PA
Lifestyle and Fertility Study on Antioxidant Status, Diet and Early Pregnancy
Antioxidant Status, Diet and Early Pregnancy
Status: Enrolling
Updated: 3/30/2016
Penn State University
mi
from
University Park, PA
Click here to add this to my saved trials
Study of Effectiveness and Safety of Azithromycin-based Extended-spectrum Prophylaxis to Prevent Post Cesarean Infection
Cesarean Section Optimal Antibiotic Prophylaxis Trial
Status: Enrolling
Updated:  4/1/2016
University of Alabama at Birmingham
mi
from
Birmingham, AL
Study of Effectiveness and Safety of Azithromycin-based Extended-spectrum Prophylaxis to Prevent Post Cesarean Infection
Cesarean Section Optimal Antibiotic Prophylaxis Trial
Status: Enrolling
Updated: 4/1/2016
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Study of Effectiveness and Safety of Azithromycin-based Extended-spectrum Prophylaxis to Prevent Post Cesarean Infection
Cesarean Section Optimal Antibiotic Prophylaxis Trial
Status: Enrolling
Updated:  4/1/2016
University of Mississippi Medical Center
mi
from
Jackson, MS
Study of Effectiveness and Safety of Azithromycin-based Extended-spectrum Prophylaxis to Prevent Post Cesarean Infection
Cesarean Section Optimal Antibiotic Prophylaxis Trial
Status: Enrolling
Updated: 4/1/2016
University of Mississippi Medical Center
mi
from
Jackson, MS
Click here to add this to my saved trials
Study of Effectiveness and Safety of Azithromycin-based Extended-spectrum Prophylaxis to Prevent Post Cesarean Infection
Cesarean Section Optimal Antibiotic Prophylaxis Trial
Status: Enrolling
Updated:  4/1/2016
Columbia University
mi
from
New York, NY
Study of Effectiveness and Safety of Azithromycin-based Extended-spectrum Prophylaxis to Prevent Post Cesarean Infection
Cesarean Section Optimal Antibiotic Prophylaxis Trial
Status: Enrolling
Updated: 4/1/2016
Columbia University
mi
from
New York, NY
Click here to add this to my saved trials
Study of Effectiveness and Safety of Azithromycin-based Extended-spectrum Prophylaxis to Prevent Post Cesarean Infection
Cesarean Section Optimal Antibiotic Prophylaxis Trial
Status: Enrolling
Updated:  4/1/2016
Mission Hospital
mi
from
Ashville, NC
Study of Effectiveness and Safety of Azithromycin-based Extended-spectrum Prophylaxis to Prevent Post Cesarean Infection
Cesarean Section Optimal Antibiotic Prophylaxis Trial
Status: Enrolling
Updated: 4/1/2016
Mission Hospital
mi
from
Ashville, NC
Click here to add this to my saved trials
Study of Effectiveness and Safety of Azithromycin-based Extended-spectrum Prophylaxis to Prevent Post Cesarean Infection
Cesarean Section Optimal Antibiotic Prophylaxis Trial
Status: Enrolling
Updated:  4/1/2016
Univ of North Carolina
mi
from
Chapel Hill, NC
Study of Effectiveness and Safety of Azithromycin-based Extended-spectrum Prophylaxis to Prevent Post Cesarean Infection
Cesarean Section Optimal Antibiotic Prophylaxis Trial
Status: Enrolling
Updated: 4/1/2016
Univ of North Carolina
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Study of Effectiveness and Safety of Azithromycin-based Extended-spectrum Prophylaxis to Prevent Post Cesarean Infection
Cesarean Section Optimal Antibiotic Prophylaxis Trial
Status: Enrolling
Updated:  4/1/2016
University of Texas Medical Branch
mi
from
Galveston, TX
Study of Effectiveness and Safety of Azithromycin-based Extended-spectrum Prophylaxis to Prevent Post Cesarean Infection
Cesarean Section Optimal Antibiotic Prophylaxis Trial
Status: Enrolling
Updated: 4/1/2016
University of Texas Medical Branch
mi
from
Galveston, TX
Click here to add this to my saved trials
Study of Effectiveness and Safety of Azithromycin-based Extended-spectrum Prophylaxis to Prevent Post Cesarean Infection
Cesarean Section Optimal Antibiotic Prophylaxis Trial
Status: Enrolling
Updated:  4/1/2016
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Study of Effectiveness and Safety of Azithromycin-based Extended-spectrum Prophylaxis to Prevent Post Cesarean Infection
Cesarean Section Optimal Antibiotic Prophylaxis Trial
Status: Enrolling
Updated: 4/1/2016
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Study of Effectiveness and Safety of Azithromycin-based Extended-spectrum Prophylaxis to Prevent Post Cesarean Infection
Cesarean Section Optimal Antibiotic Prophylaxis Trial
Status: Enrolling
Updated:  4/1/2016
University of Utah
mi
from
Salt Lake City, UT
Study of Effectiveness and Safety of Azithromycin-based Extended-spectrum Prophylaxis to Prevent Post Cesarean Infection
Cesarean Section Optimal Antibiotic Prophylaxis Trial
Status: Enrolling
Updated: 4/1/2016
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Study of Effectiveness and Safety of Azithromycin-based Extended-spectrum Prophylaxis to Prevent Post Cesarean Infection
Cesarean Section Optimal Antibiotic Prophylaxis Trial
Status: Enrolling
Updated:  4/1/2016
Ochsner Clinic Foundation
mi
from
New Orleans, LA
Study of Effectiveness and Safety of Azithromycin-based Extended-spectrum Prophylaxis to Prevent Post Cesarean Infection
Cesarean Section Optimal Antibiotic Prophylaxis Trial
Status: Enrolling
Updated: 4/1/2016
Ochsner Clinic Foundation
mi
from
New Orleans, LA
Click here to add this to my saved trials
Eltrombopag Olamine in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia
Phase I Dose-Finding Study of Eltrombopag Following High Dose Cytarabine and Mitoxantrone in Relapsed/Refractory Patients With Acute Myeloid Leukemia
Status: Enrolling
Updated:  4/4/2016
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Eltrombopag Olamine in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia
Phase I Dose-Finding Study of Eltrombopag Following High Dose Cytarabine and Mitoxantrone in Relapsed/Refractory Patients With Acute Myeloid Leukemia
Status: Enrolling
Updated: 4/4/2016
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Click here to add this to my saved trials
Eltrombopag Olamine in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia
Phase I Dose-Finding Study of Eltrombopag Following High Dose Cytarabine and Mitoxantrone in Relapsed/Refractory Patients With Acute Myeloid Leukemia
Status: Enrolling
Updated:  4/4/2016
Emory University/Winship Cancer Institute
mi
from
Atlanta, GA
Eltrombopag Olamine in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia
Phase I Dose-Finding Study of Eltrombopag Following High Dose Cytarabine and Mitoxantrone in Relapsed/Refractory Patients With Acute Myeloid Leukemia
Status: Enrolling
Updated: 4/4/2016
Emory University/Winship Cancer Institute
mi
from
Atlanta, GA
Click here to add this to my saved trials
Acupuncture for the Prevention of Postdates Pregnancy
A Randomized Controlled Trial of Acupuncture to Prevent Postdates Pregnancy
Status: Enrolling
Updated:  4/5/2016
UNC-Chapel Hill Family Medicine Center
mi
from
Chapel Hill, NC
Acupuncture for the Prevention of Postdates Pregnancy
A Randomized Controlled Trial of Acupuncture to Prevent Postdates Pregnancy
Status: Enrolling
Updated: 4/5/2016
UNC-Chapel Hill Family Medicine Center
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Phase I Combination of Midostaurin, Bortezomib, and Chemo in Relapsed/Refractory Acute Myeloid Leukemia
Phase I Study of the Combination of Midostaurin, Bortezomib, and Chemotherapy in Relapsed/Refractory Acute Myeloid Leukemia
Status: Enrolling
Updated:  4/5/2016
Ohio State University Medical Center
mi
from
Columbus, OH
Phase I Combination of Midostaurin, Bortezomib, and Chemo in Relapsed/Refractory Acute Myeloid Leukemia
Phase I Study of the Combination of Midostaurin, Bortezomib, and Chemotherapy in Relapsed/Refractory Acute Myeloid Leukemia
Status: Enrolling
Updated: 4/5/2016
Ohio State University Medical Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Perimenopausal Estrogen Replacement Therapy Study
Depression, Estrogen Replacement, and Cardiovascular Health in the Perimenopause
Status: Enrolling
Updated:  4/6/2016
Univ of North Carolina
mi
from
Chapel Hill, NC
Perimenopausal Estrogen Replacement Therapy Study
Depression, Estrogen Replacement, and Cardiovascular Health in the Perimenopause
Status: Enrolling
Updated: 4/6/2016
Univ of North Carolina
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Permeability MRI in Cerebral Cavernous Malformations Type 1 in New Mexico: Effects of Statins
Permeability MRI in Cerebral Cavernous Malformations Type 1 in New Mexico: Effects of Statins
Status: Enrolling
Updated:  4/7/2016
University of New Mexico Health Sciences Center
mi
from
Albuquerque, NM
Permeability MRI in Cerebral Cavernous Malformations Type 1 in New Mexico: Effects of Statins
Permeability MRI in Cerebral Cavernous Malformations Type 1 in New Mexico: Effects of Statins
Status: Enrolling
Updated: 4/7/2016
University of New Mexico Health Sciences Center
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)
Status: Enrolling
Updated:  4/8/2016
University of Alabama
mi
from
Birmingham, AL
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)
Status: Enrolling
Updated: 4/8/2016
University of Alabama
mi
from
Birmingham, AL
Click here to add this to my saved trials
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)
Status: Enrolling
Updated:  4/8/2016
University of South Alabama
mi
from
Mobile, AL
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)
Status: Enrolling
Updated: 4/8/2016
University of South Alabama
mi
from
Mobile, AL
Click here to add this to my saved trials
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)
Status: Enrolling
Updated:  4/8/2016
University of Arkansas
mi
from
Little Rock, AR
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)
Status: Enrolling
Updated: 4/8/2016
University of Arkansas
mi
from
Little Rock, AR
Click here to add this to my saved trials
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)
Status: Enrolling
Updated:  4/8/2016
The University of California Irvine
mi
from
Orange, CA
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)
Status: Enrolling
Updated: 4/8/2016
The University of California Irvine
mi
from
Orange, CA
Click here to add this to my saved trials
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)
Status: Enrolling
Updated:  4/8/2016
University of California San Francisco Medical Center
mi
from
San Fransisco, CA
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)
Status: Enrolling
Updated: 4/8/2016
University of California San Francisco Medical Center
mi
from
San Fransisco, CA
Click here to add this to my saved trials
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)
Status: Enrolling
Updated:  4/8/2016
Yale-New Haven Hospital
mi
from
New Haven, CT
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)
Status: Enrolling
Updated: 4/8/2016
Yale-New Haven Hospital
mi
from
New Haven, CT
Click here to add this to my saved trials
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)
Status: Enrolling
Updated:  4/8/2016
University of South Florida
mi
from
Tampa, FL
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)
Status: Enrolling
Updated: 4/8/2016
University of South Florida
mi
from
Tampa, FL
Click here to add this to my saved trials